Royal Bank of Canada »

Tourmaline Bio shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-09-30 $61k 2.4k 24.92
2024-06-30 $27k 2.4k 11.15

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Bk Nova Cad (BNS)
Ishares Tr Russell 2000 Etf (IWM)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Enbridge (ENB)
Cibc Cad (CM)

View all positions for Royal Bank of Canada

Top funds holding Tourmaline Bio

RA Capital Management
venBio Select Advisor
BlackRock
Blue Owl Capital Holdings
TCG Crossover Management
Vanguard Group
Jennison Associates
Qiming U.S. Ventures Management
Rtw Investments
QVT Financial
Nantahala Capital Management
Vivo Capital
Millennium Management
Geode Capital Management
Citadel Advisors

View all funds holding Tourmaline Bio